Fulton Breakefield Broenniman LLC Has $544,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fulton Breakefield Broenniman LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 1,612 shares of the medical equipment provider’s stock after selling 30 shares during the period. Fulton Breakefield Broenniman LLC’s holdings in Intuitive Surgical were worth $544,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. OFI Invest Asset Management bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at about $25,000. Baystate Wealth Management LLC lifted its stake in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the last quarter. MCF Advisors LLC grew its holdings in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 40 shares during the period. Headinvest LLC acquired a new position in Intuitive Surgical during the third quarter worth approximately $28,000. Finally, Stone House Investment Management LLC raised its stake in Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares during the period. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Truist Financial lifted their target price on Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Stifel Nicolaus lifted their price objective on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, April 8th. Wells Fargo & Company increased their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. BTIG Research raised their target price on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. Finally, Robert W. Baird decreased their price target on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating on the stock in a research note on Friday, April 19th. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $396.17.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $375.33 on Friday. The firm has a market cap of $133.13 billion, a PE ratio of 67.75, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36. The stock’s fifty day moving average price is $386.19 and its two-hundred day moving average price is $346.29. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter last year, the business earned $1.00 earnings per share. Intuitive Surgical’s revenue was up 11.5% on a year-over-year basis. Sell-side analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 196 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now owns 1,842 shares of the company’s stock, valued at approximately $736,800. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction on Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The disclosure for this sale can be found here. Insiders have sold a total of 249,418 shares of company stock valued at $96,300,959 in the last ninety days. 0.90% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.